Myriad Genetics – Prostate Cancer Medical Management
Dr. Thomas Slavin, Chief Medical Officer at Myriad Genetics and board-certified in clinical genetics and molecular diagnostics discusses how genetic insights can provide better risk stratification at biopsy and how testing can guide treatment recommendation. One study found that 60% of providers cited a lack of knowledge of genetic testing and the inadequate coordination of referrals as barriers to treatment.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Thomas Slavin, Chief Medical Officer at Myriad Genetics and board-certified in clinical genetics and molecular diagnostics discusses how genetic insights can provide better risk…
- Key Point: One study found that 60% of providers cited a lack of knowledge of genetic testing and the inadequate coordination of referrals as barriers to treatment.
- Key Point: Thomas (T.J.) Slavin is Chief Medical Officer of Myriad Genetics.
- Key Point: He is a physician-scientist, triple-board-certified in clinical genetics, molecular diagnostics and pediatrics.
- Key Point: Focused on expanding genetics education for cancer care providers, Dr.
Dr. Thomas (T.J.) Slavin is Chief Medical Officer of Myriad Genetics. He is a physician-scientist, triple-board-certified in clinical genetics, molecular diagnostics and pediatrics. Focused on expanding genetics education for cancer care providers, Dr. Slavin has helped shape both ASCO University as well as City of Hope’s hereditary genomics training program. He is a well-respected researcher in the field of medical genetics, publishing over 75 journal articles collectively evaluating genomic data from over 500,000 patients, multiple book chapters, and providing numerous presentations at national and international medical meetings.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


